These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 20166207

  • 1. Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance.
    Rigolin GM, Maffei R, Rizzotto L, Ciccone M, Sofritti O, Daghia G, Cibien F, Cavazzini F, Marasca R, Cuneo A.
    Cancer; 2010 Apr 15; 116(8):1926-37. PubMed ID: 20166207
    [Abstract] [Full Text] [Related]

  • 2. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
    Go RS, Jobe DA, Asp KE, Callister SM, Mathiason MA, Meyer LA, Bottner WA, Cole CE, Farnen JP, Frisby KA.
    Ann Hematol; 2008 May 15; 87(5):369-73. PubMed ID: 18193423
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.
    Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar 15; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
    Caballero D, García-Marco JA, Martino R, Mateos V, Ribera JM, Sarrá J, León A, Sanz G, de la Serna J, Cabrera R, González M, Sierra J, San Miguel J.
    Clin Cancer Res; 2005 Nov 01; 11(21):7757-63. PubMed ID: 16278397
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
    Mauro FR, Gentile M, Mancini F, Giannarelli D, Guarini A, De Propriis MS, Cerretti R, Foa R.
    Haematologica; 2002 Jun 01; 87(6):602-8. PubMed ID: 12031916
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
    Molica S.
    Haematologica; 1997 Jun 01; 82(6):705-9. PubMed ID: 9499672
    [Abstract] [Full Text] [Related]

  • 16. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
    Del Papa N, Colombo G, Fracchiolla N, Moronetti LM, Ingegnoli F, Maglione W, Comina DP, Vitali C, Fantini F, Cortelezzi A.
    Arthritis Rheum; 2004 Apr 01; 50(4):1296-304. PubMed ID: 15077314
    [Abstract] [Full Text] [Related]

  • 17. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
    Lu G, Kong Y, Yue C.
    Cancer Genet Cytogenet; 2010 Jan 01; 196(1):56-63. PubMed ID: 19963136
    [Abstract] [Full Text] [Related]

  • 18. [Lymphocyte immunophenotyping and cytogenetics for more precise prognosis in patients with type B chronic lymphatic leukemia].
    Cmunt E, Michalová K, Karban J, Zemanová Z, Sindelárová L, Bosáková Z, Brezinová J, Kurková S, Schwarz J.
    Cas Lek Cesk; 2003 Feb 01; 142(2):106-11. PubMed ID: 12698539
    [Abstract] [Full Text] [Related]

  • 19. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
    Michalová K, Zemanová Z, Cmunt E, Karban J, Brezinová J, Sindelárová L, Kurková S, Kubcová S, Schwarz J.
    Cas Lek Cesk; 2000 Jun 07; 139(11):334-8. PubMed ID: 10953412
    [Abstract] [Full Text] [Related]

  • 20. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
    Zucchetto A, Bomben R, Dal Bo M, Sonego P, Nanni P, Rupolo M, Bulian P, Dal Maso L, Del Poeta G, Del Principe MI, Degan M, Gattei V.
    J Cell Physiol; 2006 May 07; 207(2):354-63. PubMed ID: 16331666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.